{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T16:51:17Z","timestamp":1788367877194,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["72574132"],"award-info":[{"award-number":["72574132"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["72474125"],"award-info":[{"award-number":["72474125"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Special fund for Science and Technology Innovation Teams of Shanxi Province","award":["202304051001017"],"award-info":[{"award-number":["202304051001017"]}]},{"name":"Fundamental Research Program of Shanxi Province","award":["202303021221132"],"award-info":[{"award-number":["202303021221132"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00210-025-04868-4","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T07:39:03Z","timestamp":1765179543000},"page":"7361-7376","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluating adverse events of antibacterials in infants: insights from FDA adverse event reporting system (FAERS) data"],"prefix":"10.1007","volume":"399","author":[{"given":"Kai","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixuan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peifeng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"4868_CR1","unstructured":"Agency EM (n.d.) Signal management\u2014designated medical events [EB\/OL]. (4\/12\/2025). [8\/1\/2025]. https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/post-authorisation\/pharmacovigilance-post-authorisation\/signal-management"},{"issue":"12","key":"4868_CR2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.75992","volume":"16","author":"MG Aguilar","year":"2024","unstructured":"Aguilar MG, Alhussen HA, Gandhi PD et al (2024) Sepsis-associated acute kidney injury: pathophysiology and treatment modalities [J]. Cureus 16(12):e75992. https:\/\/doi.org\/10.7759\/cureus.75992","journal-title":"Cureus"},{"key":"4868_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13100977","author":"A Akta\u015f","year":"2024","unstructured":"Akta\u015f A, Ekren BY, Ya\u015fa B et al (2024) Investigation of the impact of antibiotic administration on the preterm infants\u2019 gut microbiome using next-generation sequencing-based 16S rRNA gene analysis. Antibiotics. https:\/\/doi.org\/10.3390\/antibiotics13100977","journal-title":"Antibiotics"},{"issue":"3","key":"4868_CR4","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/cpt.166","volume":"98","author":"K Allegaert","year":"2015","unstructured":"Allegaert K, Van Den Anker J (2015) Neonatal drug therapy: the first frontier of therapeutics for children. Clin Pharmacol Ther 98(3):288\u2013297. https:\/\/doi.org\/10.1002\/cpt.166","journal-title":"Clin Pharmacol Ther"},{"key":"4868_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/ftox.2024.1489310","volume":"6","author":"SM Azzam","year":"2024","unstructured":"Azzam SM, Elsanhory HMA, Abd El-Slam AH et al (2024) Protective effects of Pelargonium graveolens (geranium) oil against cefotaxime-induced hepato-renal toxicity in rats. Front Toxicol 6:1489310. https:\/\/doi.org\/10.3389\/ftox.2024.1489310","journal-title":"Front Toxicol"},{"issue":"4","key":"4868_CR6","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s002280050466","volume":"54","author":"A Bate","year":"1998","unstructured":"Bate A, Lindquist M, Edwards IR et al (1998) A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol 54(4):315\u201321. https:\/\/doi.org\/10.1007\/s002280050466","journal-title":"Eur J Clin Pharmacol"},{"key":"4868_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13051119","author":"NH Borges","year":"2025","unstructured":"Borges NH, Suss PH, Ortis GB et al (2025) Synergistic activity of vancomycin and gentamicin against Staphylococcus aureus biofilms on polyurethane surface. Microorganisms. https:\/\/doi.org\/10.3390\/microorganisms13051119","journal-title":"Microorganisms"},{"issue":"10440","key":"4868_CR8","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","volume":"403","author":"M Brauer","year":"2024","unstructured":"Brauer M, Roth GA, Aravkin AY et al (2024) Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 403(10440):2162\u2013203. https:\/\/doi.org\/10.1016\/S0140-6736(24)00933-4","journal-title":"Lancet"},{"issue":"7","key":"4868_CR9","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1007\/s00213-022-06125-5","volume":"239","author":"SC Britch","year":"2022","unstructured":"Britch SC, Walsh SL (2022) Treatment of opioid overdose: current approaches and recent advances. Psychopharmacology 239(7):2063\u20132081. https:\/\/doi.org\/10.1007\/s00213-022-06125-5","journal-title":"Psychopharmacology"},{"key":"4868_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjoq-2024-002847","author":"J Cheong","year":"2025","unstructured":"Cheong J, Boreland S, Shattock E et al (2025) Improving ototoxicity monitoring in patients receiving aminoglycosides using a novel digital approach: a quality improvement project. BMJ Open Qual. https:\/\/doi.org\/10.1136\/bmjoq-2024-002847","journal-title":"BMJ Open Qual"},{"issue":"7","key":"4868_CR11","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2165\/00003088-200443070-00001","volume":"43","author":"M De Hoog","year":"2004","unstructured":"De Hoog M, Mouton JW, Van Den Anker JN (2004) Vancomycin: pharmacokinetics and administration regimens in neonates. Clin Pharmacokinet 43(7):417\u2013440. https:\/\/doi.org\/10.2165\/00003088-200443070-00001","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"4868_CR12","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/MPG.0000000000001334","volume":"64","author":"R Fawaz","year":"2017","unstructured":"Fawaz R, Baumann U, Ekong U et al (2017) Guideline for the evaluation of cholestatic jaundice in infants: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 64(1):154\u201368. https:\/\/doi.org\/10.1097\/MPG.0000000000001334","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"7","key":"4868_CR13","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1203\/00006450-199904020-01676","volume":"45","author":"AM Fine","year":"1999","unstructured":"Fine AM, Love K, Bratton B et al (1999) Incidence and risk factors for cholestasis in neonates receiving total parenteral nutrition: 1995\u201398 [J]. Pediatr Res 45(7):282. https:\/\/doi.org\/10.1203\/00006450-199904020-01676","journal-title":"Pediatr Res"},{"issue":"4","key":"4868_CR14","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s40272-025-00690-w","volume":"27","author":"Y Gao","year":"2025","unstructured":"Gao Y, Wu T, Pu L et al (2025) Risk factors for nephrotoxicity among neonates receiving vancomycin: a systematic review and meta-analysis. Paediatr Drugs 27(4):439\u201348. https:\/\/doi.org\/10.1007\/s40272-025-00690-w","journal-title":"Paediatr Drugs"},{"issue":"12","key":"4868_CR15","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1038\/s41564-019-0550-2","volume":"4","author":"AJ Gasparrini","year":"2019","unstructured":"Gasparrini AJ, Wang B, Sun X et al (2019) Persistent metagenomic signatures of early-life hospitalization and antibiotic treatment in the infant gut microbiota and resistome. Nat Microbiol 4(12):2285\u20132297. https:\/\/doi.org\/10.1038\/s41564-019-0550-2","journal-title":"Nat Microbiol"},{"key":"4868_CR16","doi-asserted-by":"publisher","unstructured":"GBD (2021) Fertility and Forecasting Collaborators. Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. Lancet. 2024 May 18;403(10440):2057-2099. https:\/\/doi.org\/10.1016\/s0140-6736(24)00550-6","DOI":"10.1016\/s0140-6736(24)00550-6"},{"key":"4868_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/phar.70044","author":"RK Goyal","year":"2025","unstructured":"Goyal RK, Moffett BS, Parbuoni KA et al (2025) A large cohort study to identify risk factors of acute kidney injury in pediatric patients undergoing intravenous vancomycin therapy. Pharmacotherapy. https:\/\/doi.org\/10.1002\/phar.70044","journal-title":"Pharmacotherapy"},{"issue":"6","key":"4868_CR18","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.otc.2021.07.003","volume":"54","author":"SJ Gustafson","year":"2021","unstructured":"Gustafson SJ, Corbin NE (2021) Pediatric hearing loss guidelines and consensus statements-where do we stand? Otolaryngol Clin North Am 54(6):1129\u20131142. https:\/\/doi.org\/10.1016\/j.otc.2021.07.003","journal-title":"Otolaryngol Clin North Am"},{"key":"4868_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2025.107816","volume":"206","author":"R Hajialibabaei","year":"2025","unstructured":"Hajialibabaei R, Sayeli FG, Aghadavood E et al (2025) The beneficial role of probiotics and gut microbiota in signaling pathways, immunity, apoptosis, autophagy, and intestinal barrier for effective wound healing post-burn injury. Microb Pathog 206:107816. https:\/\/doi.org\/10.1016\/j.micpath.2025.107816","journal-title":"Microb Pathog"},{"issue":"1","key":"4868_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-025-00960-w","volume":"26","author":"C Jiang","year":"2025","unstructured":"Jiang C, Qian J, Lu Y et al (2025) Exploration of adverse event profiles for cefotaxime: a disproportionality analysis using the FDA adverse event reporting system. BMC Pharmacol Toxicol 26(1):129. https:\/\/doi.org\/10.1186\/s40360-025-00960-w","journal-title":"BMC Pharmacol Toxicol"},{"key":"4868_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23042052","author":"WC Kan","year":"2022","unstructured":"Kan WC, Chen YC, Wu VC et al (2022) Vancomycin-associated acute kidney injury: a narrative review from pathophysiology to clinical application. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23042052","journal-title":"Int J Mol Sci"},{"issue":"25","key":"4868_CR22","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1056\/NEJMra1005408","volume":"383","author":"W Kim","year":"2020","unstructured":"Kim W, Seo JM (2020) Necrotizing enterocolitis. N Engl J Med 383(25):2461. https:\/\/doi.org\/10.1056\/NEJMra1005408","journal-title":"N Engl J Med"},{"key":"4868_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11081063","author":"GG Kournoutou","year":"2022","unstructured":"Kournoutou GG, Dinos G (2022) Azithromycin through the lens of the COVID-19 treatment. Antibiotics. https:\/\/doi.org\/10.3390\/antibiotics11081063","journal-title":"Antibiotics"},{"issue":"5","key":"4868_CR24","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1080\/23744235.2024.2315478","volume":"56","author":"C Kraef","year":"2024","unstructured":"Kraef C, Hertz FB, Riis Olesen B et al (2024) Empiric treatment of healthcare-associated central nervous system infections in Denmark: do we need carbapenems? Infect Dis 56(5):402\u20139. https:\/\/doi.org\/10.1080\/23744235.2024.2315478","journal-title":"Infect Dis"},{"issue":"4","key":"4868_CR25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1136\/bmjqs-2023-016971","volume":"34","author":"L Lin","year":"2025","unstructured":"Lin L (2025) Global, regional and national time trends in incidence of adverse effects of medical treatment, 1990-2019: an age-period-cohort analysis from the Global Burden of Disease 2019 study. BMJ Qual Saf 34(4):223\u2013233. https:\/\/doi.org\/10.1136\/bmjqs-2023-016971","journal-title":"BMJ Qual Saf"},{"issue":"3","key":"4868_CR26","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/cid\/cir353","volume":"52","author":"C Liu","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE et al (2011) Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary [J]. Clin Infect Dis 52(3):285\u2013292. https:\/\/doi.org\/10.1093\/cid\/cir353","journal-title":"Clin Infect Dis"},{"issue":"4","key":"4868_CR27","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1113\/expphysiol.2011.059303","volume":"97","author":"W Marcotti","year":"2012","unstructured":"Marcotti W (2012) Functional assembly of mammalian cochlear hair cells. Exp Physiol 97(4):438\u2013451. https:\/\/doi.org\/10.1113\/expphysiol.2011.059303","journal-title":"Exp Physiol"},{"issue":"11","key":"4868_CR28","doi-asserted-by":"publisher","first-page":"4334","DOI":"10.1111\/bcp.14851","volume":"87","author":"JL Montastruc","year":"2021","unstructured":"Montastruc JL, Lafaurie M, De Canecaude C et al (2021) Fatal adverse drug reactions: a worldwide perspective in the World Health Organization pharmacovigilance database. Br J Clin Pharmacol 87(11):4334\u201340. https:\/\/doi.org\/10.1111\/bcp.14851","journal-title":"Br J Clin Pharmacol"},{"key":"4868_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s40780-015-0035-2","volume":"1","author":"M Nakamura","year":"2015","unstructured":"Nakamura M, Umetsu R, Abe J et al (2015) Analysis of the time-to-onset of osteonecrosis of jaw with bisphosphonate treatment using the data from a spontaneous reporting system of adverse drug events. J Pharm Health Care Sci 1:34. https:\/\/doi.org\/10.1186\/s40780-015-0035-2","journal-title":"J Pharm Health Care Sci"},{"issue":"3","key":"4868_CR30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1056\/NEJMra1005408","volume":"364","author":"J Neu","year":"2011","unstructured":"Neu J, Walker WA (2011) Necrotizing enterocolitis. N Engl J Med 364(3):255\u2013264. https:\/\/doi.org\/10.1056\/NEJMra1005408","journal-title":"N Engl J Med"},{"issue":"1","key":"4868_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-017-0248-8","volume":"5","author":"M Pammi","year":"2017","unstructured":"Pammi M, Cope J, Tarr PI et al (2017) Intestinal dysbiosis in preterm infants preceding necrotizing enterocolitis: a systematic review and meta-analysis. Microbiome 5(1):31. https:\/\/doi.org\/10.1186\/s40168-017-0248-8","journal-title":"Microbiome"},{"issue":"2","key":"4868_CR32","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S2352-4642(21)00311-4","volume":"6","author":"J Perin","year":"2022","unstructured":"Perin J, Mulick A, Yeung D et al (2022) Global, regional, and national causes of under-5 mortality in 2000-19: an updated systematic analysis with implications for the Sustainable Development Goals. The Lancet Child & Adolescent Health 6(2):106\u2013115. https:\/\/doi.org\/10.1016\/S2352-4642(21)00311-4","journal-title":"The Lancet Child & Adolescent Health"},{"issue":"10","key":"4868_CR33","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s40264-013-0061-7","volume":"36","author":"O Sauzet","year":"2013","unstructured":"Sauzet O, Carvajal A, Escudero A et al (2013) Illustration of the weibull shape parameter signal detection tool using electronic healthcare record data. Drug Saf 36(10):995\u20131006. https:\/\/doi.org\/10.1007\/s40264-013-0061-7","journal-title":"Drug Saf"},{"issue":"7","key":"4868_CR34","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1007\/s00467-020-04784-0","volume":"36","author":"SK Sethi","year":"2021","unstructured":"Sethi SK, Rana A, Bansal SB et al (2021) A rare complication of pauci-immune crescentic glomerulonephritis in a child: questions. Pediatr Nephrol 36(7):1947\u20131948. https:\/\/doi.org\/10.1007\/s00467-020-04784-0","journal-title":"Pediatr Nephrol"},{"key":"4868_CR35","doi-asserted-by":"publisher","first-page":"789","DOI":"10.2147\/clep.s365513","volume":"14","author":"Y Shu","year":"2022","unstructured":"Shu Y, He X, Liu Y et al (2022) A real-world disproportionality analysis of olaparib: data mining of the public version of FDA adverse event reporting system. Clin Epidemiol 14:789\u2013802. https:\/\/doi.org\/10.2147\/clep.s365513","journal-title":"Clin Epidemiol"},{"issue":"3","key":"4868_CR36","doi-asserted-by":"publisher","first-page":"198","DOI":"10.21037\/tp-20-134","volume":"9","author":"JY Ting","year":"2020","unstructured":"Ting JY, Shah PS (2020) Antibiotic stewardship in neonates: challenges and opportunities. Transl Pediatr 9(3):198\u2013201. https:\/\/doi.org\/10.21037\/tp-20-134","journal-title":"Transl Pediatr"},{"issue":"1","key":"4868_CR37","doi-asserted-by":"publisher","DOI":"10.1080\/20523211.2025.2514155","volume":"18","author":"B Tong","year":"2025","unstructured":"Tong B, Wang J, Zhang Y et al (2025) A real-world study based on the FAERS database evaluating adverse drug reactions in three amphotericin B lipid formulations. J Pharm Policy Pract 18(1):2514155. https:\/\/doi.org\/10.1080\/20523211.2025.2514155","journal-title":"J Pharm Policy Pract"},{"issue":"5","key":"4868_CR38","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1097\/MPG.0000000000002655","volume":"70","author":"CHP Van Den Akker","year":"2020","unstructured":"Van Den Akker CHP, Van Goudoever JB, Shamir R et al (2020) Probiotics and preterm infants: a position paper by the European Society for Paediatric Gastroenterology Hepatology and Nutrition Committee on Nutrition and the European Society for Paediatric Gastroenterology Hepatology and Nutrition Working Group for Probiotics and Prebiotics. J Pediatr Gastroenterol Nutr 70(5):664\u201380. https:\/\/doi.org\/10.1097\/MPG.0000000000002655","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"4868_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/falgy.2024.1458688","volume":"5","author":"J Wurm","year":"2024","unstructured":"Wurm J, Curtis N, Zimmermann P (2024) The effect of antibiotics on the intestinal microbiota in children - a systematic review. Front Allergy 5:1458688. https:\/\/doi.org\/10.3389\/falgy.2024.1458688","journal-title":"Front Allergy"},{"key":"4868_CR40","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/978-981-13-7647-4_7","volume":"1141","author":"X Yang","year":"2019","unstructured":"Yang X, Han L (2019) Roles of renal drug transporter in drug disposition and renal toxicity. Adv Exp Med Biol 1141:341\u2013360. https:\/\/doi.org\/10.1007\/978-981-13-7647-4_7","journal-title":"Adv Exp Med Biol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04868-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04868-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04868-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T04:16:36Z","timestamp":1776312996000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04868-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["4868"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04868-4","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"assertion":[{"value":"13 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study conducts a secondary analysis of reported data from the public database FAERS and does not require ethical approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have agreed to the publication of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}